Hemorrhage in posterior reversible encephalopathy syndrome: Imaging and clinical features

American Journal of Neuroradiology

Volumn 30, Issue 7, 2009, Pages 1371-1379

  Hefzy, H M ^a   Bartynski, Walter S ^a,b   Boardman, J F ^a   Lacomis, D ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; CYCLOSPORIN; GADOBENATE DIMEGLUMINE; GADOLINIUM PENTETATE; GADOTERIDOL; HEPARIN; IOHEXOL; IOVERSOL; MEGLUMINE IOTALAMATE; TACROLIMUS; WARFARIN;

ADULT; AGED; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BLOOD CLOTTING; BLOOD PRESSURE; BRAIN HEMORRHAGE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEMATOMA; HUMAN; HYPERTENSION; IMAGING SYSTEM; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGAN TRANSPLANTATION; PATIENT ASSESSMENT; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; SUBARACHNOID HEMORRHAGE; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

ADULT; AGED; CEREBRAL HEMORRHAGE; COMORBIDITY; FEMALE; HUMANS; INCIDENCE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PENNSYLVANIA; POSTERIOR LEUKOENCEPHALOPATHY SYNDROME; RISK ASSESSMENT; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 68549111125     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: 10.3174/ajnr.A1588     Document Type: Article

References (77)

1. Gocmen R, Ozgen B, Oguz KK. Widening the spectrum of PRES: series from a tertiary care center. Eur J Radiol 2007;62:454-459 Epub 2007 Jan 10 (Pubitemid 46783357)
2. Ahn KJ, You WJ, Jeong SL, et al. Atypical manifestations of reversible posterior leukoencephalopathy syndrome: findings on diffusion imaging and ADC mapping. Neuroradiology 2004;46:978-983
3. Bartynski WS, Boardman JF. Distinct imaging patterns and lesion distribution in posterior reversible encephalopathy syndrome (PRES). AJNR Am J Neuroradiol 2007;28:1320-1327
4. Bartynski WS. Posterior reversible encephalopathy syndrome. Part 1. Fundamental imaging and clinical features. AJNR Am J Neuroradiol 2008;29:1036-1042 (Pubitemid 351954863)
5. McKinney AM, Short J, Truwit CL, et al. Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings. AJR Am J Roentgenol 2007;189:904-912 (Pubitemid 47485623)
6. Gijtenbeek JM, van den Bent MJ, Vecht CJ. Cyclosporine neurotoxicity: a review. J Neurol 1999;246:339-346
7. Garg RK. Posterior leukoencephalopathy syndrome. Postgrad Med J 2001;77:24-28
8. Lee VH, Wijdicks EF, Manno EM, et al. Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Arch Neurol 2008;65:205-210 (Pubitemid 351240781)
9. Colosimo C Jr, Fileni A, Moschini M, et al. CT findings in eclampsia. Neuroradiology 1985;27:313-317
10. Fisher M, Maister B, Jacobs R. Hypertensive encephalopathy: diffuse reversible white matter CT abnormalities. Ann Neurol 1985;18:268-270
11. Lewis LK, Hinshaw DB Jr, Will AD, et al. CT and angiographic correlation of severe neurological disease in toxemia of pregnancy. Neuroradiology 1988;30:59-64
12. Naheedy MH, Biller J, Schiffer M, et al. Toxemia of pregnancy: cerebral CT findings. J Comput Assist Tomogr 1985;9:497-501
13. de Groen PC, Aksamit AJ, Rakela J, et al. Central nervous system toxicity after liver transplantation: the role of cyclosporine and cholesterol. N Engl J Med 1987;317:861-866 (Pubitemid 17156729)
14. Ghalie R, Fitzsimmons WE, Bennett D, et al. Cortical blindness: a rare complication of cyclosporine therapy. Bone Marrow Transplant 1990;6:147-149 (Pubitemid 20270764)
15. Rail DL, Perkin GD. Computerized tomographic appearance of hypertensive encephalopathy. Arch Neurol 1980;37:310-311 (Pubitemid 10000977)
16. Reece DE, Frei-Lahr DA, Shepherd JD, et al. Neurologic complications in allogeneic bone marrow transplant patients receiving cyclosporin. Bone Marrow Transplant 1991;8:393-401
17. Trommer BL, Homer D, Mikhael MA. Cerebral vasospasm and eclampsia. Stroke 1988;19:326-329
18. Truwit CL, Denaro CP, Lake JR, et al. MR imaging of reversible cyclosporin A-induced neurotoxicity. AJNR Am J Neuroradiol 1991;12:651-659
19. Waldron RL 2nd, Abbott DC, Vellody D. Computed tomography in preeclampsia- eclampsia syndrome. AJNR Am J Neuroradiol 1985;6:442-443
20. Weingarten KL, Zimmerman RD, Pinto RS, et al. Computed tomographic changes of hypertensive encephalopathy. AJNR Am J Neuroradiol 1985;6:395-398
21. Will AD, Lewis KL, Hinshaw DB Jr, et al. Cerebral vasoconstriction in toxemia. Neurology 1987;37:1555-1557
22. Wilson SE, de Groen PC, Aksamit AJ, et al. Cyclosporin A-induced reversible cortical blindness. J Clin Neuroophthalmol 1988;8:215-220 (Pubitemid 19007789)
23. Raroque HG Jr, Orrison WW, Rosenberg GA. Neurologic involvement in toxemia of pregnancy: reversible MRI lesions. Neurology 1990;40:167-169
24. Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996;334:494-500
25. Coughlin WF, McMurdo SK, Reeves T. MR imaging of postpartum cortical blindness. J Comput Assist Tomogr 1989;13:572-576
26. Toole JF. Lacunar syndromes and hypertensive encephalopathy. In: Toole JF, ed. Cerebrovascular Disorders. 5th ed. New York: Raven; 1999:342-355
27. Bartynski WS, Zeigler ZR, Shadduck RK, et al. Variable incidence of cyclosporine and FK-506 neurotoxicity in hematopoietic malignancies and marrow conditions after allogeneic bone marrow transplantation. Neurocrit Care 2005;3:33-45
28. Bartynski WS. Posterior reversible encephalopathy syndrome. Part 2. Controversies surrounding pathophysiology of vasogenic edema. AJNR Am J Neuroradiol 2008;29:1043-1049
29. Strandgaard S, Olesen J, Skinhoj E, et al. Autoregulation of brain circulation in severe arterial hypertension. BMJ 1973;1:507-510
30. Kitaguchi H, Tomimoto H, Miki Y, et al. A brainstem variant of reversible posterior leukoencephalopathy syndrome. Neuroradiology 2005;47:652-656 (Pubitemid 41403606)
31. Brubaker LM, Smith JK, Lee YZ, et al. Hemodynamic and permeability changes in posterior reversible encephalopathy syndrome measured by dynamic susceptibility perfusion-weighted MR imaging. AJNR Am J Neuroradiol 2005;26:825-830
32. Bartynski WS, Boardman JF. Catheter angiography, MR angiography, and MR perfusion in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol 2008;29:447-455
33. Bartynski WS, Grabb BC, Zeigler Z, et al. Watershed imaging features and clinical vascular injury in cyclosporin A neurotoxicity. J Comput Assist Tomogr 1997;21:872-880 (Pubitemid 28049575)
34. Engelter ST, Petrella JR, Alberts MJ, et al. Assessment of cerebral microcirculation in a patient with hypertensive encephalopathy using MR perfusion imaging. AJR Am J Roentgenol 1999;173:1491-1493
35. Naidu K, Moodley J, Corr P, et al. Single photon emission and cerebral computerised tomographic scan and transcranial Doppler sonographic findings in eclampsia. Br J Obstet Gynaecol 1997;104:1165-1172 (Pubitemid 27406488)
36. Singhal AB. Postpartum angiopathy with reversible posterior leukoencephalopathy. Arch Neurol 2004;61:411-416 (Pubitemid 38327360)
37. Doss-Esper CE, Singhal AB, Smith MS, et al. Reversible posterior leukoencephalopathy, cerebral vasoconstriction, and strokes after intravenous immune globulin therapy in Guillain-Barre syndrome. J Neuroimaging 2005;15:188-192
38. Bartynski WS, Zeigler ZR, Shadduck RK, et al. Pretransplantation conditioning influence on the occurrence of cyclosporine or FK-506 neurotoxicity in allogeneic bone marrow transplantation. AJNR Am J Neuroradiol 2004;25:261-269
39. Zimmer WE, Hourihane JM, Wang HZ, et al. The effect of human leukocyte antigen disparity on cyclosporine neurotoxicity after allogeneic bone marrow transplantation. AJNR Am J Neuroradiol 1998;19:601-08, discussion 609-610 (Pubitemid 30422701)
40. Zoja C, Furci L, Ghilardi F, et al. Cyclosporin-induced endothelial cell injury. Lab Invest 1986;55:455-462
41. Kochi S, Takanaga H, Matsuo H, et al. Effect of cyclosporin A or tacrolimus on the function of blood-brain barrier cells. Eur J Pharmacol 1999;372:287-295 (Pubitemid 29255970)
42. Kochi S, Takanaga H, Matsuo H, et al. Induction of apoptosis in mouse brain capillary endothelial cells by cyclosporin A and tacrolimus. Life Sci 2000;66:2255-2260 (Pubitemid 30256625)
43. Ramanathan V, Helderman JH. Cyclosporine formulations. In: Sayegh M, Remuzzi G, eds. Current and Future Immunosuppressive Therapies Following Transplantation. the Netherlands: Kluwer Academic; 2001:111-121
44. Shapiro R. Tacrolimus. In: Sayegh M, Remuzzi G, eds. Current and Future Immunosuppressive Therapies Following Transplantation. the Netherlands: Kluwer Academic; 2001:123-142
45. Benigni A, Morigi M, Perico N, et al. The acute effect of FK506 and cyclosporine on endothelial cell function and renal vascular resistance. Transplantation 1992;54:775-780
46. Marsen TA, Weber F, Egink G, et al. Cyclosporin A induces prepro endothelin- 1 gene transcription in human endothelial cells. Eur J Pharmacol 1999;379:97-106 (Pubitemid 29492952)
47. Kon V, Sugiura M, Inagami T, et al. Role of endothelin in cyclosporine-induced glomerular dysfunction. Kidney Int 1990;37:1487-1491 (Pubitemid 20198030)
48. Bartynski WS, Boardman JF, Zeigler ZR, et al. Posterior reversible encephalopathy syndrome in infection, sepsis, and shock. AJNR Am J Neuroradiol 2006;27:2179-2190 (Pubitemid 44788652)
49. Bartynski WS, Tan HP, Boardman JF, et al. Posterior reversible encephalopathy syndrome after solid organ transplantation. AJNR Am J Neuroradiol 2008;29:924-930 (Pubitemid 351684968)
50. Casey SO, McKinney A, Teksam M, et al. CT perfusion imaging in the management of posterior reversible encephalopathy. Neuroradiology 2004;46:272-276 (Pubitemid 38594248)
51. Pan J, Konstas AA, Bateman B, et al. Reperfusion injury following cerebral ischemia: pathophysiology, MR imaging, and potential therapies. Neuroradiology 2007;49:93-102
52. Horbinski C, Bartynski WS, Carson-Walter E, et al. Reversible encephalopathy after cardiac transplantation: histologic evidence of endothelial activation, T-cell specific trafficking, and vascular endothelial growth factor expression. AJNR Am J Neuroradiol 2009;30:588-590
53. Paciaroni M, Agnelli G, Corea F, et al. Early hemorrhagic transformation of brain infarction: rate, predictive factors, and influence on clinical outcome - results of a prospective multicenter study. Stroke 2008;39:2249-2256
54. Thanvi BR, Treadwell S, Robinson T. Haemorrhagic transformation in acute ischaemic stroke following thrombolysis therapy: classification, pathogenesis and risk factors. Postgrad Med J 2008;84:361-367
55. Teal PA, Pessin MS. Hemorrhagic transformation: the spectrum of ischemia-related brain hemorrhage. Neurosurg Clin N Am 1992;3:601-610
56. Ferrer I, Kaste M, Kalimo H. Vascular diseases. In: Love S, Louis DN, Ellison DW, eds. Greenfield's Neuropathology. 8th ed. London, UK: Hodder Arnold; 2008:121-240
57. Rabinstein AA, Weigand S, Atkinson JL, Wijdicks EF. Patterns of cerebral infarction in aneurysmal subarachnoid hemorrhage. Stroke 2005;36:992-997 (Pubitemid 40629290)
58. Weidauer S, Lanfermann H, Raabe A, et al. Impairment of cerebral perfusion and infarct patterns attributable to vasospasm after aneurysmal subarachnoid hemorrhage: a prospective MRI and DSA study. Stroke 2007;38:1831-1836 (Pubitemid 46847255)
59. Edlow BL, Kasner SE, Hurst RW, et al. Reversible cerebral vasoconstriction syndrome associated with subarachnoid hemorrhage. Neurocrit Care 2007;7:203-210 (Pubitemid 350242641)
60. Singhal AB. Cerebral vasoconstriction syndromes. Top Stroke Rehabil 2004;11:1-6
61. Adams CW. Perivascular iron deposition and other vascular damage in multiple sclerosis. J Neurol Neurosurg Psychiatry 1988;51:260-265
62. Prineas JW, McDonald WI, Franklin RJM. Demyelinating diseases. In: Graham DI, Lantos PL, eds. Greenfield's Neuropathology. 7th ed. London, UK: Arnold; 2002:471-550
63. Dale RC. Acute disseminated encephalomyelitis. Semin Pediatr Infect Dis 2003;14:90-95
64. Hynson JL, Kornberg AJ, Coleman LT, et al. Clinical and neuroradiologic features of acute disseminated encephalomyelitis in children. Neurology 2001;56:1308-1312 (Pubitemid 32455289)
65. Tenembaum S, Chamoles N, Fejerman N. Acute disseminated encephalomyelitis: a long-term follow-up study of 84 pediatric patients. Neurology 2002;59:1224-1231 (Pubitemid 35192393)
66. Lee HY, Chang KH, Kim JH, et al. Serial MR imaging findings of acute hemorrhagic leukoencephalitis: a case report. AJNR Am J Neuroradiol 2005;26:1996-1999
67. Hart MN, Earle KM. Haemorrhagic and perivenous encephalitis: a clinical-pathological review of 38 cases. J Neurol Neurosurg Psychiatry 1975;38:585-591
68. Sobel R, Moore GRW. Demyelinating disease. In: Love S, Louis DN, Ellison DW, eds. Greenfield's Neuropathology. 8th ed. London, UK: Hodder Arnold; 2008:1513-1608
69. Kuperan S, Ostrow P, Landi MK, et al. Acute hemorrhagic leukoencephalitis vs ADEM: FLAIR MRI and neuropathology findings. Neurology 2003;60:721-722 (Pubitemid 36246101)
70. Vartanian TK, Monte S. Case records of the Massachusetts General Hospital: weekly clinicopathological exercises - case 1-1999. A 53-year-old man with fever and rapid neurologic deterioration. N Engl J Med 1999;340:127-135
71. Gibbs WN, Kreidie MA, Kim RC, et al. Acute hemorrhagic leukoencephalitis: neuroimaging features and neuropathologic diagnosis. J Comput Assist Tomogr 2005;29:689-693
72. Klein CJ, Wijdicks EF, Earnest FT. Full recovery after acute hemorrhagic leukoencephalitis (Hurst's disease). J Neurol 2000;247:977-979
73. Mader I, Wolff M, Niemann G, et al. Acute haemorrhagic encephalomyelitis (AHEM): MRI findings. Neuropediatrics 2004;35:143-146 (Pubitemid 38639324)
74. Markus R, Brew BJ, Turner J, et al. Successful outcome with aggressive treatment of acute haemorrhagic leukoencephalitis. J Neurol Neurosurg Psychiatry 1997;63:551 (Pubitemid 27423573)
75. Bartynski WS, Upadhyaya A, Boardman JF. Posterior reversible encephalopathy syndrome (PRES) and cerebral vasculopathy associated with influenza A infection: report of a case and review of the literature. J Comput Assist Tomogr 2009, In press
76. Haacke EM, Mittal S, Wu Z, et al. Susceptibility-weighted imaging: technical aspects and clinical applications, part 1. AJNR Am J Neuroradiol 2009;30:19-30. Epub 2009 Jan 8
77. Mittal S, Wu Z, Neelavalli J, et al. Susceptibility-weighted imaging: technical aspects and clinical applications, part 2. AJNR Am J Neuroradiol 2009;30:232-252 Epub 2009 Jan 8